Speakers:
- Jeremy Rock, Associate Professor, Rockefeller University (USA)
- Dirk Schnappinger, Professor, Department of Microbiology & Immunology, Weill Cornell Medical College (USA)
- Laura Cleghorn, Reader, Drug Discovery Unit, School of Life Sciences, University of Dundee (UK)
Moderator:
- Valerie Mizrahi, Director, Institute of Infectious Disease and Molecular Medicine, University of Cape Town (South Africa)
This webinar will explore the current landscape of drug discovery for tuberculosis, focusing on both the scientific and practical challenges that hinder progress, as well as the opportunities that emerging technologies and novel targets present.
Presentation 1: Identifying vulnerable targets and pathways in M. tuberculosis (Jeremy Rock)
Presentation 2: The application of chemical-genetic tools in TB drug discovery (Dirk Schnappinger)
Presentation 3: Opportunities and challenges in TB drug discovery: targeting Pks13 as a case study (Laura Cleghorn)
This live webinar including an interactive Q&A session will be broadcast on 9 September 2025. Find your timezone here.
If you have questions or comments, please let us know: revive@gardp.org.